Prognostic Significance of Vascular Endothelial Growth Factor, Basic Fibroblast Growth Factor, and Angiogenin in Patients With Resectable Hepatocellular Carcinoma After Surgery-Reference-Cited by-同舟云学术

Prognostic Significance of Vascular Endothelial Growth Factor, Basic Fibroblast Growth Factor, and Angiogenin in Patients With Resectable Hepatocellular Carcinoma After Surgery

Published:2003-01 Issue:4 Volume:10 Page:355-362
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Chao Yee,Li Chung-Ping,Chau Gar-Yang,Chen Chih-Ping,King Kuang-Liang,Lui Wing-Yiu,Yen Sang-Hue,Chang Full-Young,Chan Wing-Kai,Lee Shou-Dong

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

http://link.springer.com/content/pdf/10.1245/ASO.2003.10.002.pdf

Reference46 articles.

1. Simonetti RG, Camma C, Fiorello F, Politi F, D?Amico G, Pagliaro L. Hepatocellular carcinoma. A worldwide problem and the major risk factors. Dig Dis Sci 1991;36:962?72.

2. Simonetti RG, Liberati A, Angiolini C, Pagliaro L. Treatment of hepatocellular carcinoma: a systemic review of randomized controlled trials. Ann Oncol 1997;8:117?36.

3. Lui WY, Chau GY, Loong CC, et al. Hepatic segmentectomy for curative resection of primary hepatocellular carcinoma. Arch Surg 1995;130:1090?7.

4. Poon RT, Fan ST, Lo CM, Liu CL, Wong J. Intrahepatic recurrence after curative resection of hepatocellular carcinoma. Long term results of treatment and prognostic factors. Ann Surg 1999;229:216?22.

5. Poon RT, Fan ST, Lo CM, et al. Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years. Ann Surg 2001;234:63?70.

Cited by 180 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Survival in Patients With Recurrent Intermediate-Stage Hepatocellular Carcinoma;JAMA Oncology;2024-08-01

2. A reverse docking approach to explore the anticancer potency of natural compounds by interfering metastasis and angiogenesis;Journal of Biomolecular Structure and Dynamics;2023-08-01

3. Combined radiotherapy and immune checkpoint inhibition for the treatment of advanced hepatocellular carcinoma;Frontiers in Oncology;2023-07-24

4. Efficacy and safety of apatinib versus sorafenib/placebo in first-line treatment for intermediate and advanced primary liver cancer: A systematic review and meta-analysis;Frontiers in Pharmacology;2023-04-21

5. The Potential Utility of Circulating Oncofetal H19 Derived miR-675 Expression versus Tissue lncRNA-H19 Expression in Diagnosis and Prognosis of HCC in Egyptian Patients;Biomolecules;2022-12-20